CDC10 Antibody

What is CDC10 and why are antibodies against it important in research?

CDC10 (Cell Division Cycle 10) is a critical member of the septin family of proteins that forms filamentous structures involved in various cellular processes, including cytokinesis, membrane compartmentalization, and cell morphogenesis. In research contexts, CDC10 has been identified as Septin 7 in some mammalian studies, where it plays essential roles in cell division and differentiation processes . Antibodies against CDC10 are valuable research tools for:

• Investigating septin complex formation and dynamics

• Studying the role of septins in cell division mechanisms

• Examining cellular differentiation processes, particularly in adipogenesis

• Analyzing protein-protein interactions involving septin family members

• Visualizing septin localization through immunocytochemistry techniques

The importance of CDC10 antibodies is underscored by research demonstrating that overexpression of CDC10 can significantly impact adipocyte differentiation in both bovine intramuscular preadipocytes and 3T3-L1 cells . This makes CDC10 antibodies essential tools for studying developmental and metabolic processes.

How can I validate the specificity of a CDC10 antibody for research applications?

Validating CDC10 antibody specificity requires multiple complementary approaches to ensure reliable experimental outcomes:

Primary Validation Methods:

• Western Blot Analysis:

  • Isolate total protein using RIPA buffer supplemented with PMSF

  • Separate proteins via SDS-polyacrylamide gel electrophoresis

  • Transfer to NC membranes and block with 5% skim milk for 2 hours

  • Incubate with CDC10 primary antibody (typically 1:1000 dilution) overnight at 4°C

  • Use appropriate HRP-conjugated secondary antibody (1:10,000 dilution)

  • Detect signal using chemiluminescent reagents and confirm band at expected molecular weight

• Genetic Manipulation Confirmation:

  • Generate cells with CDC10 knockdown (using validated siRNAs) and CDC10 overexpression

  • Compare antibody signal across control, knockdown and overexpression samples

  • Verify signal reduction in knockdown conditions and enhancement in overexpression conditions

• Immunoprecipitation-Mass Spectrometry:

  • Perform immunoprecipitation using CDC10 antibody

  • Analyze precipitated proteins via mass spectrometry to confirm presence of CDC10 and known interacting partners

  • Cross-reference with published septin interaction networks

• Orthogonal Detection Methods:

  • Compare results from CDC10 protein detection with CDC10 mRNA expression via RT-PCR

  • Ensure correlation between protein and transcript levels in experimental conditions

What are recommended protocols for CDC10 antibody-based immunoprecipitation?

For optimal CDC10 immunoprecipitation results, the following methodological approach is recommended:

Optimized CDC10 Immunoprecipitation Protocol:

• Lysate Preparation:

  • Harvest cells at 70-80% confluence

  • Wash twice with ice-cold PBS

  • Lyse cells in appropriate buffer (e.g., TBS with protease inhibitors)

  • Clarify lysate by centrifugation (15,000 × g for 15 min at 4°C)

  • Quantify protein concentration via Bradford or BCA assay

• Pre-clearing Step:

  • Incubate lysate (~15 ml) with protein A/G beads for 1 hour at 4°C

  • Remove beads by gentle centrifugation

• Immunoprecipitation:

  • Add CDC10 antibody (2-5 μg per mg of total protein) to pre-cleared lysate

  • Incubate with slow end-over-end mixing for 4 hours or overnight at 4°C

  • Add 200 μl of protein A/G bead slurry

  • Incubate for an additional 1-2 hours at 4°C

  • Collect immunoprecipitate by centrifugation (1000 × g for 2 min)

• Washing and Elution:

  • Wash beads 3× with 500 μl of wash buffer (TBS with 2 M urea, pH 7.5)

  • Elute bound proteins with SDS sample buffer or a specific elution buffer

  • Analyze via western blot or prepare for mass spectrometry analysis

For downstream proteomics analysis, separation by SDS-PAGE followed by in-gel digestion is recommended over direct in-bead digestion to reduce antibody background interference that may complicate mass spectrometry results .

What experimental controls should be included when working with CDC10 antibodies?

Proper experimental controls are critical for reliable results when using CDC10 antibodies:

Essential Controls for CDC10 Antibody Experiments:

• Negative Controls:

  • Isotype control antibody (same species and isotype as CDC10 antibody)

  • Secondary antibody-only control (omitting primary antibody)

  • Cells with confirmed CDC10 knockdown via validated siRNA (e.g., CDC10-siRNA1 for bovine cells with 81% knockdown efficiency)

• Positive Controls:

  • Cell lines with confirmed CDC10 expression (e.g., 3T3-L1 cells)

  • Recombinant CDC10 protein

  • Cells with CDC10 overexpression via lentiviral transduction

• Technical Controls:

  • Loading control proteins for western blot (e.g., α-Tubulin at 1:1000 dilution)

  • Reference gene controls for RT-PCR to normalize CDC10 expression data

  • Multiple biological replicates to account for experimental variation

• Application-Specific Controls:

  • For immunohistochemistry: tissue sections known to express or lack CDC10

  • For flow cytometry: fluorescence-minus-one (FMO) controls

  • For co-immunoprecipitation: "pull-down" with non-specific IgG

How does CDC10 expression influence cell differentiation pathways in research models?

CDC10 plays a significant regulatory role in adipocyte differentiation, with expression levels directly impacting differentiation efficiency and lipid accumulation. Research findings demonstrate:

CDC10 Knockout Effects:

• Significantly reduced lipid droplet formation in both bovine intramuscular preadipocytes (BIMP) and 3T3-L1 cells

• Decreased intracellular lipid content (p < 0.01) as measured by Oil Red O extraction

• Downregulation of key adipogenic transcription factors:

  • PPARγ (p < 0.01)

  • C/EBPα (p < 0.01)

  • FABP4 (p < 0.01 in BIMP)

  • FASN (p < 0.05 in 3T3-L1)

• Increased expression of adipose triglyceride lipase (ATGL), a lipid mobilization marker (p < 0.05 in BIMP, p < 0.01 in 3T3-L1)

CDC10 Overexpression Effects:

• Significantly increased lipid droplet formation

• Enhanced intracellular lipid content (p < 0.01)

• Upregulation of adipogenic marker genes:

  • PPARγ (p < 0.05 in BIMP, p < 0.01 in 3T3-L1)

  • C/EBPα (p < 0.01 in BIMP, p < 0.05 in 3T3-L1)

  • FABP4 (p < 0.01 in both cell types)

  • FASN (p < 0.01 in BIMP)

• Decreased expression of ATGL (p < 0.01 in BIMP, p < 0.05 in 3T3-L1)

These findings establish CDC10 as a positive regulator of adipocyte differentiation, making CDC10 antibodies valuable tools for studying metabolic and differentiation processes. The methodological approach of using both knockdown and overexpression models provides complementary evidence for CDC10's regulatory role.

What are the best practices for quantitative analysis of CDC10 protein interactions?

For comprehensive analysis of CDC10 protein interactions, the following methodological approach is recommended:

Optimized Protocol for CDC10 Interaction Studies:

• Sample Preparation for Immunoprecipitation:

  • Culture cells under appropriate experimental conditions (e.g., different temperatures for studying stress responses)

  • Harvest cells and prepare lysate using optimized lysis buffer

  • Determine protein concentration to ensure equal loading

  • Pre-clear lysate to reduce non-specific binding

• Affinity Capture of CDC10 Complexes:

  • If using a tagged CDC10 construct (e.g., CDC10-mCherry), use appropriate tag-specific reagents:

    • mCherry-NHS Mag Sepharose slurry (200 μl)

    • ChromoTek RFP-Trap® agarose beads (200 μl)

  • Incubate lysate (~15 ml) with affinity matrix for 1 hour with end-over-end mixing at 4°C

  • Wash beads thoroughly with appropriate buffer (TBS with 2 M urea, pH 7.5)

• Protein Complex Analysis:

  • Resolve protein complexes via SDS-PAGE

  • Perform in-gel digestion rather than in-bead digestion to reduce background

  • Analyze digested peptides using GeLC-MS/MS on an Orbitrap fusion instrument

  • Identify interacting proteins using appropriate database search algorithms

• Data Analysis and Validation:

  • Filter protein identifications using statistical criteria

  • Validate key interactions using reciprocal co-immunoprecipitation

  • Confirm interactions using orthogonal methods (e.g., proximity ligation assay)

  • Use appropriate software for interaction network visualization

How can CDC10 antibodies be used to study septin dynamics under stress conditions?

CDC10 antibodies are valuable tools for investigating septin dynamics under various stress conditions, particularly temperature stress in pathogenic fungi like Cryptococcus neoformans:

Methodological Approach for Stress Response Studies:

• Experimental Design for Stress Conditions:

  • Grow cells under normal conditions and stress conditions (e.g., high temperature)

  • For temperature stress in C. neoformans, compare 30°C (normal) vs. 37°C (stress)

  • Include appropriate time points to capture dynamic changes

• Comparative Immunoprecipitation:

  • Perform parallel immunoprecipitations from control and stressed samples

  • Use CDC10 antibody or tagged CDC10 constructs for pulldown

  • Process samples identically to ensure comparability

• Mass Spectrometry Analysis:

  • Analyze immunoprecipitated complexes to identify stress-specific interactions

  • Use quantitative proteomics approaches (e.g., SILAC, TMT) to compare protein abundance

  • Look for proteins that specifically associate with CDC10 under stress conditions

• Microscopy-Based Approaches:

  • Use CDC10 antibodies for immunofluorescence to visualize septin relocalization

  • Combine with live-cell imaging using fluorescently tagged septins

  • Analyze changes in septin complex formation and localization in response to stress

What antibody validation criteria should be applied for CDC10 antibodies used in advanced research applications?

For advanced research applications, rigorous validation of CDC10 antibodies is essential to ensure reliable results:

Advanced Validation Criteria and Methods:

• Genetic Knockout/Knockdown Controls:

  • Generate CDC10 knockout cell lines or tissues using CRISPR-Cas9

  • Create knockdown models using validated siRNAs (e.g., CDC10-siRNA1 with 81% knockdown efficiency for bovine cells)

  • Compare antibody signal across wild-type and knockout/knockdown samples

• Independent Antibody Validation:

  • Test multiple antibodies targeting different epitopes of CDC10

  • Compare staining patterns and results to confirm specificity

  • Use orthogonal detection methods (e.g., mass spectrometry) to confirm target identity

• Cross-Reactivity Assessment:

  • Test CDC10 antibody against other septin family members

  • Perform immunoprecipitation followed by mass spectrometry to identify all bound proteins

  • Ensure specificity against closely related proteins within the septin family

• Application-Specific Validation:

  • For immunohistochemistry: compare with RNA in situ hybridization

  • For chromatin immunoprecipitation: confirm binding sites with orthogonal methods

  • For super-resolution microscopy: validate localization patterns with complementary approaches

• Reproducibility Assessment:

  • Test antibody performance across different lots and sources

  • Document validation data including positive and negative controls

  • Ensure consistent performance across experimental replicates

How can CDC10 antibodies be used to distinguish between different septin complex formations?

Septins form heteromeric complexes with distinct compositions and functions. CDC10 antibodies can be strategically employed to investigate these different complexes:

Methodological Strategies:

• Sequential Immunoprecipitation Approach:

  • First immunoprecipitation: Use CDC10 antibody to pull down all CDC10-containing complexes

  • Elution: Release complexes under mild conditions

  • Second immunoprecipitation: Use antibodies against other septin family members

  • Analysis: Identify unique complex compositions by mass spectrometry or western blotting

• Blue Native PAGE Analysis:

  • Isolate native protein complexes using non-denaturing conditions

  • Separate complexes based on size using Blue Native PAGE

  • Perform western blotting with CDC10 antibody

  • Identify distinct complex sizes and compositions

• Immunofluorescence Co-localization:

  • Perform double or triple immunofluorescence staining with:

    • CDC10 antibody

    • Antibodies against other septin family members

    • Markers for cellular structures (e.g., actin, microtubules)

  • Analyze co-localization patterns to identify distinct septin complex localizations

• Proximity Ligation Assay (PLA):

  • Use CDC10 antibody in combination with antibodies against potential interacting proteins

  • Perform PLA to visualize and quantify specific protein-protein interactions in situ

  • Compare interaction patterns under different conditions or in different cell types

What are common challenges in CDC10 antibody experiments and how can they be addressed?

Researchers frequently encounter several challenges when working with CDC10 antibodies. Here are methodological solutions to address these issues:

Challenge: High Background in Immunofluorescence

• Solution: Optimize blocking conditions using different blocking agents (BSA, normal serum, commercial blockers)

• Method: Test blocking with 5% BSA, 10% normal serum, or commercial blocking reagents for 1-2 hours

• Validation: Compare signal-to-noise ratio across different blocking methods

Challenge: Weak or Absent Signal in Western Blots

• Solution: Optimize antibody concentration, incubation conditions, and detection methods

• Method: Test different antibody dilutions (1:500 to 1:2000), incubation times (overnight at 4°C vs. 2 hours at room temperature), and enhanced chemiluminescence substrates

• Validation: Include positive control samples with known CDC10 expression

Challenge: Non-specific Bands in Western Blots

• Solution: Increase stringency of washing steps and optimize blocking

• Method: Use TBS-T with 0.1-0.3% Tween-20 for washing, increase wash duration and number of washes

• Validation: Compare with CDC10 knockout/knockdown samples to identify specific bands

Challenge: Interference from Antibody Chains in Immunoprecipitation-Mass Spectrometry

• Solution: Use SDS-PAGE separation and in-gel digestion instead of direct in-bead digestion

• Method: After immunoprecipitation, elute proteins, separate by SDS-PAGE, and perform in-gel digestion of selected gel regions

• Validation: This approach reduces antibody contamination in mass spectrometry samples

How can CDC10 antibody performance be optimized for different experimental conditions?

Optimizing CDC10 antibody performance requires tailored approaches for different experimental conditions:

For Western Blot Analysis:

• Protein extraction: Use RIPA buffer supplemented with PMSF for optimal CDC10 preservation

• Protein loading: 20-30 μg per lane typically provides optimal signal

• Membrane type: NC membranes show better performance than PVDF for CDC10 detection

• Blocking: 5% skim milk for 2 hours provides optimal blocking

• Antibody dilution: 1:1000 dilution of primary antibody with overnight incubation at 4°C

• Detection: Use enhanced chemiluminescence with Tanon-5200 imaging system

For Immunofluorescence:

• Fixation: 4% paraformaldehyde for 15 minutes at room temperature

• Permeabilization: 0.1% Triton X-100 for 10 minutes

• Blocking: 5% normal serum from the same species as the secondary antibody

• Antibody dilution: Start with 1:100 to 1:500 dilution range

• Counterstaining: Include appropriate cytoskeletal or nuclear stains to provide context

For Immunoprecipitation:

• Lysis buffer: TBS with protease inhibitors for general applications

• Antibody amount: 2-5 μg antibody per mg of total protein

• Incubation: Overnight at 4°C with gentle rotation

• Washing: Multiple washes with TBS containing 2 M urea (pH 7.5)

For Flow Cytometry:

• Fixation: 2% paraformaldehyde for 15 minutes

• Permeabilization: 0.1% saponin or 0.1% Triton X-100

• Antibody dilution: Start with 1:50 to 1:200 dilution range

• Controls: Include fluorescence-minus-one controls and isotype controls

What methodological approaches can be used to study CDC10 phosphorylation states with antibodies?

Studying CDC10 phosphorylation requires specialized approaches:

Method 1: Phospho-specific CDC10 Antibodies

• Selection of phospho-specific antibodies:

  • Choose antibodies specifically targeting known CDC10 phosphorylation sites

  • Validate with phosphatase-treated negative controls

  • Include phosphorylation-inducing conditions as positive controls

• Phosphorylation detection protocol:

  • Treat cells with phosphatase inhibitors during lysis (e.g., sodium orthovanadate, sodium fluoride)

  • Use Phos-tag™ SDS-PAGE for enhanced separation of phosphorylated forms

  • Detect with phospho-specific CDC10 antibodies

Method 2: Phosphorylation-Dependent Mobility Shift Analysis

• Sample preparation:

  • Prepare parallel samples: untreated and treated with lambda phosphatase

  • Resolve proteins using standard SDS-PAGE or Phos-tag™ gels

  • Detect CDC10 using standard CDC10 antibodies

  • Compare mobility shifts between treated and untreated samples

Method 3: Immunoprecipitation-Mass Spectrometry

• Enrichment of phosphorylated CDC10:

  • Immunoprecipitate CDC10 using validated antibodies

  • Enrich for phosphopeptides using TiO₂ or IMAC

  • Analyze by LC-MS/MS with neutral loss scanning

  • Map identified phosphorylation sites to CDC10 sequence

How can CDC10 antibodies be used in comparative studies across different model organisms?

CDC10 is evolutionarily conserved but shows species-specific variations that can be exploited for comparative studies:

Methodological Approach for Cross-Species Studies:

• Antibody Selection Strategy:

  • Choose antibodies raised against conserved epitopes of CDC10

  • Validate cross-reactivity across target species

  • Consider using multiple antibodies targeting different epitopes to account for species variation

• Comparative Analysis Protocol:

  • Standardize protein extraction methods across species

  • Normalize loading based on total protein rather than single housekeeping genes

  • Use western blot to compare CDC10 expression levels and electrophoretic mobility

  • Document species-specific differences in CDC10 molecular weight and modification patterns

• Functional Conservation Assessment:

  • Compare CDC10 localization patterns across species using immunofluorescence

  • Analyze protein interaction networks via immunoprecipitation-mass spectrometry

  • Identify conserved vs. species-specific interaction partners

  • Correlate findings with known functional differences

What are the considerations for using CDC10 antibodies in multiplexed imaging approaches?

Multiplexed imaging allows simultaneous visualization of multiple targets and provides contextual information about CDC10 localization and interactions:

Methodological Considerations:

• Antibody Compatibility Assessment:

  • Test CDC10 antibodies with other target antibodies for cross-reactivity

  • Ensure primary antibodies are from different host species

  • Validate specificity of secondary antibodies

  • Perform single-staining controls before multiplexing

• Optimized Multiplexing Protocol:

  • Sequential immunostaining: Apply, image, and strip/quench each antibody sequentially

  • Spectral unmixing: Use confocal microscopy with spectral detection to separate overlapping fluorophores

  • Tyramide signal amplification: Enhance signal detection for low-abundance targets

  • Proximity ligation: Visualize CDC10 interactions with specific partners

• Advanced Imaging Approaches:

  • CODEX (CO-Detection by indEXing): For highly multiplexed tissue imaging

  • Imaging Mass Cytometry: For simultaneous detection of 40+ proteins

  • 4i (iterative indirect immunofluorescence imaging): For cyclic immunofluorescence with 40+ targets

How can computational approaches enhance CDC10 antibody-based research?

Computational methods can significantly enhance the value of CDC10 antibody-based research:

Computational Enhancement Strategies:

• Image Analysis Automation:

  • Machine learning-based segmentation of CDC10-stained structures

  • Automated quantification of CDC10 localization patterns

  • Correlation analysis with other cellular markers

  • High-content screening approaches for phenotypic profiling

• Network Analysis of CDC10 Interactome:

  • Integration of immunoprecipitation-mass spectrometry data into protein interaction networks

  • Functional enrichment analysis of CDC10-associated proteins

  • Comparison of interaction networks across conditions or species

  • Prediction of functional modules within the CDC10 interactome

• Structure-Function Relationship Modeling:

  • Epitope mapping of CDC10 antibodies using computational approaches

  • Prediction of antibody binding sites based on CDC10 protein structure

  • Molecular dynamics simulations to understand CDC10 complex formation

  • Virtual screening for small molecule modulators of CDC10 function

What are the best practices for reporting CDC10 antibody usage in scientific publications?

To ensure reproducibility and transparency in CDC10 antibody research, the following reporting standards are recommended:

Comprehensive Reporting Guidelines:

• Antibody Identification:

  • Manufacturer, catalog number, lot number, and RRID (Research Resource Identifier)

  • Clone name for monoclonal antibodies

  • Host species and immunogen used for antibody generation

  • Mention of any modifications (e.g., conjugated fluorophores)

• Validation Evidence:

  • Description of validation methods used (western blot, immunofluorescence, etc.)

  • Include controls (positive, negative, isotype)

  • Present validation data in supplementary materials

  • Cite previous validation studies if applicable

• Experimental Conditions:

  • Detailed methods section with complete protocol information

  • Antibody dilutions and incubation conditions

  • Buffer compositions

  • Image acquisition parameters

  • Quantification methods

• Data Availability:

  • Raw data deposition in appropriate repositories

  • Sharing of full-length blots and unedited images

  • Code used for image analysis and data processing

  • Detailed protocols in repositories like protocols.io

What are the current knowledge gaps and future research directions for CDC10 antibody applications?

Despite significant progress in CDC10 research, several knowledge gaps and future research directions remain:

Current Knowledge Gaps:

• Cell-Type Specific Functions:

  • Limited understanding of CDC10 expression and function across different tissue types

  • Incomplete characterization of cell-type specific CDC10 interactors

  • Need for conditional knockout models to study tissue-specific roles

• Post-Translational Modifications:

  • Limited data on CDC10 phosphorylation sites and their functional significance

  • Incomplete understanding of how modifications affect CDC10 complex formation

  • Need for modification-specific antibodies

• Pathological Relevance:

  • Limited exploration of CDC10's role in disease processes

  • Incomplete characterization in cancer, metabolic disorders, and developmental conditions

  • Potential as a therapeutic target or biomarker

Future Research Directions:

• Development of Conformation-Specific Antibodies:

  • Antibodies specifically recognizing different functional states of CDC10

  • Tools to distinguish CDC10 in different septin complexes

  • Antibodies specific to post-translationally modified CDC10

• Multi-Omics Integration:

  • Combining CDC10 antibody-based proteomics with transcriptomics and metabolomics

  • Systems biology approaches to understand CDC10 regulatory networks

  • Integration with single-cell technologies for cell-type specific insights

• Therapeutic and Diagnostic Applications:

  • Exploration of CDC10 as a potential biomarker

  • Development of CDC10-targeting therapeutic strategies

  • Application in tissue engineering based on CDC10's role in cell differentiation